BioSig Technologies, Inc. financial data

Symbol
BSGM on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
55 Greens Farms Road, Westport, CT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 28.2 % -59.7%
Quick Ratio 8.18 % -89.6%
Debt-to-equity -207 % -166%
Return On Equity 860 %
Return On Assets -743 % -7.54%
Operating Margin -47.4K % -310%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.3M shares -78.3%
Common Stock, Shares, Outstanding 15.1M shares -79.4%
Entity Public Float 77M USD +174%
Common Stock, Value, Issued 15K USD -79.5%
Weighted Average Number of Shares Outstanding, Basic 12.9M shares +83.8%
Weighted Average Number of Shares Outstanding, Diluted 12.9M shares +83.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 40K USD -85.5%
Research and Development Expense 2.9M USD -48.4%
General and Administrative Expense 15.5M USD -40.4%
Operating Income (Loss) -18.9M USD +40.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.5M USD +45.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -17.9M USD +43.5%
Earnings Per Share, Basic -1.84 USD/shares +81%
Earnings Per Share, Diluted -1.84 USD/shares +81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 200K USD -50%
Accounts Receivable, after Allowance for Credit Loss, Current 54K USD +157%
Inventory, Net 219K USD -87%
Other Assets, Current 5K USD
Assets, Current 2.39M USD +20.1%
Property, Plant and Equipment, Net 137K USD -77.9%
Operating Lease, Right-of-Use Asset 257K USD -54.2%
Other Assets, Noncurrent 44K USD 0%
Assets 3.11M USD -23.3%
Contract with Customer, Liability, Current 16K USD
Liabilities, Current 2.98M USD -10.7%
Operating Lease, Liability, Noncurrent 15K USD -94.7%
Liabilities 2.99M USD -17.2%
Retained Earnings (Accumulated Deficit) -252M USD -7.65%
Stockholders' Equity Attributable to Parent -4.32M USD -319%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -4.31M USD -326%
Liabilities and Equity 3.11M USD -23.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.31M USD +76.7%
Net Cash Provided by (Used in) Financing Activities 1.54M USD -77.2%
Net Cash Provided by (Used in) Investing Activities -45K USD +18.2%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 15.1M shares -79.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.1M USD +68.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 55.4M USD +16.2%
Operating Lease, Liability 282K USD -53.9%
Depreciation 293K USD -9.47%
Payments to Acquire Property, Plant, and Equipment 45K USD -18.2%
Lessee, Operating Lease, Liability, to be Paid 292K USD -55.5%
Property, Plant and Equipment, Gross 1.04M USD -25.4%
Operating Lease, Liability, Current 267K USD -19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 106K USD -71.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 106K USD -41.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10K USD -77.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 106K USD -71.4%
Deferred Tax Assets, Operating Loss Carryforwards 43.3M USD +17.2%
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 106K USD
Additional Paid in Capital 252M USD +7.56%
Depreciation, Depletion and Amortization 312K USD -9.04%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 1.06M USD -50.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%